Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty
- Conditions
- Heart Failure, SystolicFrailty
- Interventions
- First Posted Date
- 2021-02-08
- Last Posted Date
- 2021-02-15
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 40000
- Registration Number
- NCT04743063
- Locations
- 🇺🇸
Brigham And Women's Hospital, Boston, Massachusetts, United States
Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 19002
- Registration Number
- NCT04736719
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 6066
- Registration Number
- NCT04736433
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 78605
- Registration Number
- NCT04736420
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 18028
- Registration Number
- NCT04736693
- Locations
- 🇺🇸
Brigham And Women's Hospital, Boston, Massachusetts, United States
Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 5350
- Registration Number
- NCT04735523
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
A Nurse-led, Advance Care Planning Intervention in the Emergency Department
Not Applicable
Completed
- Conditions
- Emergency DepartmentAdvance Care PlanningMotivational Interviewing
- Interventions
- Behavioral: ED GOAL Nursing
- First Posted Date
- 2021-01-29
- Last Posted Date
- 2022-06-24
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT04730986
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial)
Phase 1
- Conditions
- Chronic Kidney DiseasesHyperkalemia
- Interventions
- Drug: Sodium Zirconium Cyclosilicate Oral Product
- First Posted Date
- 2021-01-27
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04727840
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Microdevice in Ovarian, Fallopian Tube, and Peritoneal Cancer
Phase 1
Recruiting
- Conditions
- Peritoneal CancerFallopian Tube Cancer Stage IVFallopian Tube CancerOvarian Cancer Stage IIIFallopian Tube Cancer Stage IIIOvarian CancerOvarian Cancer Stage IV
- Interventions
- Combination Product: Microdevice
- First Posted Date
- 2021-01-08
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04701645
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Methotrexate vs Hydroxychloroquine
- First Posted Date
- 2020-12-31
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 133553
- Registration Number
- NCT04691505
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath